Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vir Biotechnology Inc (NQ: VIR )

22.34 -0.69 (-3.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,127,871
Open 23.00
Bid (Size) 22.34 (1)
Ask (Size) 23.44 (1)
Prev. Close 23.03
Today's Range 22.29 - 23.05
52wk Range 18.05 - 31.78
Shares Outstanding 133,531,379
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
 
Via Benzinga
Biotech Stocks And The SVB Collapse — Here's What We Know
The collapse of SVB will have a big impact on early-stage, venture-backed companies. 
Via Investor's Business Daily

Performance

YTD
-10.35%
-10.35%
1 Month
-17.23%
-17.23%
3 Month
-14.93%
-14.93%
6 Month
+19.47%
+19.47%
1 Year
-15.38%
-15.38%

More News

Read More
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
From Vir Biotechnology, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
Via Benzinga
Where Vir Biotechnology Stands With Analysts
Via Benzinga
Vir Biotechnology's Earnings Outlook
Via Benzinga
Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results
Via Benzinga
The Top 7 Growth Stocks in Biotech
Via InvestorPlace
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
From Vir Biotechnology, Inc.
Via Globe NewsWire
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
Via FinancialNewsMedia
Exposures COVID-19
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
From Vir Biotechnology, Inc.
Via Globe NewsWire
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)
From Vir Biotechnology, Inc.
Via Globe NewsWire
Earnings Scheduled For February 23, 2023
Via Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
Via Benzinga
DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Vir Biotechnology, Inc.
Via Globe NewsWire
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
From Vir Biotechnology, Inc.
Via Globe NewsWire
Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out
Via Benzinga
Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.